Thrombosis in central obesity and metabolic syndrome: mechanisms and epidemiology
Pierre-Emmanuel Morange1, Marie-Christine Alessi
1Marie-Christine Alessi, Laboratoire d'Hématologie, Inserm UMR 1062, Faculté de Médecine, Université de la Méditerranée, 27 Bd Jean Moulin, Marseille, F-13385 France, Tel.: +33 4 91 32 45 06, Fax: +33 4 91 25 43 36,
Abstract:
Central obesity is a key feature of the metabolic syndrome (metS), a multiplex risk factor for subsequent development of type 2 diabetes and cardiovascular disease. Many metabolic alterations closely related to this condition exert effects on platelets and vascular cells. A procoagulant and hypofibrinolytic state has been identified, mainly underlain by inflammation, oxidative stress, dyslipidaemia, and ectopic fat that accompany central obesity. In support of these data, central obesity independently predisposes not only to atherothrombosis but also to venous thrombosis.
Related Concept Videos
Venous Thrombosis I: Introduction
Cholesterol: Significance and Regulation
Considering cholesterol and...
Obesity
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Type II Diabetes I: Introduction
Coronary Artery Disease I: Introduction
